Realnova Healthcare

• Broad-Spectrum Antibiotic:
  Effective against a wide range of Gram-positive and Gram-negative bacteria.

• Beta-lactamase Inhibitor Combination:
  The Clavulanic acid component inhibits beta-lactamase enzymes, protecting Amoxycillin from degradation and extending its antibacterial spectrum.

• Powerful Bactericidal Action:
  Works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death.

• Effective Against Resistant Strains:
  Useful in infections caused by beta-lactamase–producing organisms resistant to ampicillin or amoxycillin alone.

• Rapid Onset of Action:
  Provides quick therapeutic response in severe infections when administered intravenously or intramuscularly.

• Wide Therapeutic Use:
  Indicated in respiratory tract infections, urinary tract infections, intra-abdominal infections, skin & soft tissue infections, bone and joint infections, and gynecological infections.

• Stable Formulation:
  Designed for optimal stability and potency after reconstitution for parenteral administration.

• Flexible Dosage Strengths:
  Available in various strengths (e.g., 1.2 g, 600 mg) to suit different infection severities and patient needs.

FEATURES

• Broad-spectrum antibiotic combination.

• Contains Amoxycillin (a beta-lactam antibiotic) and Potassium Clavulanate (a beta-lactamase inhibitor).

• Effective against a wide range of Gram-positive and Gram-negative bacteria.

• Helps overcome resistance caused by beta-lactamase–producing organisms.

• Indicated in the treatment of respiratory tract infections, urinary tract infections, skin & soft tissue infections, intra-abdominal infections, bone & joint infections, and gynecological infections.

• Available in sterile powder form for parenteral (IV/IM) administration.

• Provides rapid onset of action with high bioavailability.